Using CRISPR/Cas9, LRP8 has been genetically deleted, resulting in the depletion of selenocysteine required for translation of anti-ferroptosis GPX4 and making MYCN-amplified neuroblastoma vulnerable to cell death (Alborzinia et al., 2023). This evidence concerns the gene LRP8 and neuroblastoma.